Millendo Therapeutics, Inc.·4

Dec 11, 7:36 PM ET

Brinza Jeffery M. 4

4 · Millendo Therapeutics, Inc. · Filed Dec 11, 2018

Insider Transaction Report

Form 4
Period: 2018-12-07
Brinza Jeffery M.
Sec., CAO and General Counsel
Transactions
  • Award

    Employee Stock Option (right to buy)

    2018-12-07+49,60949,609 total
    Exercise: $4.44Exp: 2026-01-27Common Stock (49,609 underlying)
  • Award

    Employee Stock Option (right to buy)

    2018-12-07+44,63944,639 total
    Exercise: $16.40Exp: 2028-08-23Common Stock (44,639 underlying)
Footnotes (4)
  • [F1]Twenty-five percent (25%) of the shares subject to the option vested on August 24, 2016, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
  • [F2]Received in connection with the merger of Millendo Therapeutics, Inc. ("Millendo") into the Issuer (the "Merger") in exchange for a stock option to acquire 666,800 shares of Millendo common stock for $0.33 per share.
  • [F3]Twenty-five percent (25%) of the shares subject to the option shall vest on August 20, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
  • [F4]Received in connection with the Merger in exchange for a stock option to acquire 600,000 shares of Millendo common stock for $1.22 per share.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION